Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 4928
Country/Region: Kenya
Year: 2007
Main Partner: University of California at San Francisco
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $200,000

Funding for Treatment: Adult Treatment (HTXS): $200,000

1. LIST OF RELATED ACTIVITIES This activity relates to activities in ARV Services (#7004, #6945).

2. ACTIVITY DESCRIPTION The current focus of the ARV treatment program in Kenya is to rapidly scale up access to quality services. Although there has been very serious attention to implementation of quality services, monitoring to date has focused on measurement of the numbers of people accessing treatment more than on outcomes and adverse events. Longitudinal Surveillance of Treatment in Kenya (LSTiK) is a Kenya adaptation of L-STEP methodology to measure outcomes of treatment in a nationally representative sample of people on ART. This will include measures of retention, adherence, treatment effectiveness (including viral suppression), morbidity and mortality from longitudinal follow-up of patients. Protocol development will be performed by UCSF through UTAP in collaboration with the USG agencies, NASCOP will provide data management and coordination with USG technical assistance, and CDC-KEMRI laboratory will provide virologic/immunologic testing.